Skip to content

Burning Rock Biotech Ltd Price, Chart & Factor Analysis

Free Data & Analytics Access
Burning Rock Biotech Ltd · E.BNR.NASDAQ · United States
Use symbol E.BNR.NASDAQ in our API & Excel add-in to retrieve this data ↓
11.05
(-0.10%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum -100%
Trend -75%
Bubble Risk LOW
Realised Volatility (20D) 98.87%

Burning Rock Biotech Ltd Forecast

Burning Rock Biotech Ltd short-term momentum is strongly negative (up over 0 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term SELL signal. The long-term trend is strongly negative (1 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term SELL signal. Based on 20-day realised volatility of 98.9% a year, a typical one-standard-deviation range is 9.5110–12.59 over a week, 7.8960–14.20 over a month and 0.1244–21.98 over a year. (Signals as of 1 Nov 2026.)

Burning Rock Biotech Ltd Price Chart

MacroFinance.ai

Burning Rock Biotech Ltd Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Burning Rock Biotech Ltd
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Burning Rock Biotech Ltd
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Burning Rock Biotech Ltd
Signal
0
ⓘLatest reading of Signal.
Teal = supportive for Burning Rock Biotech Ltd, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Research on Burning Rock Biotech Ltd

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Burning Rock Biotech Ltd Trading Strategies

58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to Burning Rock Biotech Ltd; 28 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

From creators

See all 58 strategies holding SPY, XLV →

Statistical Distribution of Returns

Plus

How Burning Rock Biotech Ltd’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Burning Rock Biotech Ltd behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Burning Rock Biotech Ltd (United States)

Burning Rock Biotech Ltd is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on Brenntag SE

Frequently asked questions

What is Burning Rock Biotech Ltd?
Burning Rock Biotech Ltd is a listed security in the United States. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Burning Rock Biotech Ltd price?
The latest close is 11.05 (1 Nov 2026), -0.10% on the day. The price at the top of the page refreshes during the trading day.
Is Burning Rock Biotech Ltd in an uptrend?
As of 1 Nov 2026, short-term momentum is strongly negative (0 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly negative (1 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Burning Rock Biotech Ltd?
20-day realised volatility is 98.9% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 28.5% over a month and 13.9% over a week.
What factors affect Burning Rock Biotech Ltd?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Burning Rock Biotech Ltd, grouped as Quantitative Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Burning Rock Biotech Ltd?
58 backtested tactical asset allocation strategies trade Burning Rock Biotech Ltd through SPY, XLV; 28 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Burning Rock Biotech Ltd returns analysed?
The Statistical Distribution of Returns section shows the distribution of Burning Rock Biotech Ltd daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Burning Rock Biotech Ltd historical data?
In the Free historical data section of this page: the last 10 years of Burning Rock Biotech Ltd daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Burning Rock Biotech Ltd historical data (last 10 years)

Browse or instantly download the last 10 years of Burning Rock Biotech Ltd daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.BNR.NASDAQ&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-2013.24
2026-11-1913.32
2026-11-1813.07
2026-11-1712.5
2026-11-1612.74
2026-11-1313.29
2026-11-1213.33
2026-11-1113.24
2026-11-1012.67
2026-11-0912.39
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Burning Rock Biotech Limited develops and sells cancer therapy selection tests in the People's Republic of China and the United States. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company offers next-generation sequencing (NGS)-based tissue, liquid biopsy cancer therapy selection, and prognosis prediction tests for various cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its key products include OncoScreen Focus, a multi-gene tumor mutation co-detection test kit for non-small cell lung cancer (NSCLC) patients; OncoScreen Plus, a pan-cancer test for tissue samples; OncoCompass Plus, a corresponding test for liquid biopsy samples; OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC; and ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal and related cancers. The company also provides CanCatch, a pre-operative ctDNA detection and post-operative minimal residual disease calling for relapsed patients; OncoMaster, an automatic NGS data analysis and report interpretation machine; as well as Magnis BR-customized version of its key products. In addition, it engages in the facilitation of laboratory equipment sales and sales of reagent kits. The company has a development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; and collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, CStone, BeiGene, Abbisko Therapeutics, IMPACT Therapeutics, Boehringer Ingelheim, and Merck KGaA. Burning Rock Biotech Limited was founded in 2014 and is headquartered in Guangzhou, the People's Republic of China.